We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$71.3B
1-Year Est. Return
56.8%
This Fund
S&P 500
This Quarter
Est. Return
+24.89%
1 Year Est. Return
+56.8%
3 Year Est. Return
+170.28%
5 Year Est. Return
+249.16%
10 Year Est. Return
+1,007.9%
AUM
$71.3B
AUM Growth
+$6.48B
(+10%)
Cap. Flow
-$2.43B
Cap. Flow
% of AUM
-3.41%
Top 10 Holdings %
Top 10 Hldgs %
29.48%
Holding
1,130
New
174
Increased
291
Reduced
392
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Devon Energy
DVN
|
+$353M |
| 2 |
Marvell Technology
MRVL
|
+$150M |
| 3 |
Spyre Therapeutics
SYRE
|
+$126M |
| 4 |
BridgeBio Pharma
BBIO
|
+$116M |
| 5 |
Dover
DOV
|
+$110M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Revolution Medicines
RVMD
|
+$713M |
| 2 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$355M |
| 3 |
CTRA
Coterra Energy
CTRA
|
+$289M |
| 4 |
Royalty Pharma
RPRX
|
+$259M |
| 5 |
Eli Lilly
LLY
|
+$236M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.29% |
| 2 | Healthcare | 14.03% |
| 3 | Financials | 12.39% |
| 4 | Industrials | 8.94% |
| 5 | Communication Services | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
W.W. Grainger
GWW
$60.2B
| $67.7M | 0.09% |
49,742
-4,400
| -8% | -$5.42M |
|
202
Iron Mountain
IRM
$34.3B
| $67.6M | 0.09% |
535,152
-54,900
| -9% | -$6.73M |
|
|
MANE
203
Veradermics Inc
MANE
$4.16B
| $67.6M | 0.09% |
549,706
-550,294
| -50% | -$51.5M |
|
204
Teradyne
TER
$60B
| $67.5M | 0.09% |
139,524
-800
| -0.6% | -$302K |
|
205
DexCom
DXCM
$31.7B
| $67.3M | 0.09% |
999,900
-666,508
| -40% | -$44.4M |
|
206
Lockheed Martin
LMT
$121B
| $67.1M | 0.09% |
131,793
-52,600
| -29% | -$28.4M |
|
207
KKR & Co
KKR
$93.4B
| $67.1M | 0.09% |
731,300
+116,300
| +19% | +$11.3M |
|
208
TransDigm Group
TDG
$62.2B
| $66.5M | 0.09% |
49,894
-700
| -1% | -$860K |
|
209
Republic Services
RSG
$68.1B
| $66.2M | 0.09% |
310,491
+157,175
| +103% | +$32.9M |
|
210
SLB Ltd
SLB
$84.7B
| $66.1M | 0.09% |
1,422,467
+67,900
| +5% | +$3.64M |
|
211
Absci
ABSI
$1.48B
| $66.1M | 0.09% |
+5,704,820
| New | +$32.1M |
|
212
Elevance Health
ELV
$86.1B
| $66M | 0.09% |
170,687
+65,030
| +62% | +$24.1M |
|
213
Adobe
ADBE
$101B
| $65.7M | 0.09% |
320,278
-20,000
| -6% | -$4.74M |
|
214
United Parcel Service
UPS
$84.4B
| $65.1M | 0.09% |
605,400
+13,400
| +2% | +$1.39M |
|
215
Valero Energy
VLO
$112B
| $65M | 0.09% |
249,600
+1,400
| +0.6% | +$345K |
|
216
Accenture
ACN
$108B
| $65M | 0.09% |
522,222
-4,000
| -0.8% | -$694K |
|
217
Edwards Lifesciences
EW
$49.7B
| $64.8M | 0.09% |
716,030
+214,164
| +43% | +$17.9M |
|
218
Pool Corp
POOL
$6.47B
| $64.6M | 0.09% |
300,576
+251,376
| +511% | +$50.2M |
|
219
American International
AIG
$39.2B
| $64.3M | 0.09% |
862,538
+761,900
| +757% | +$57.9M |
|
220
Toll Brothers
TOL
$12.4B
| $64.3M | 0.09% |
390,000
+60,000
| +18% | +$8.53M |
|
221
Corteva
CTVA
$56.5B
| $64M | 0.09% |
756,037
-136,400
| -15% | -$11M |
|
222
CRH
CRH
$59.4B
| $63.7M | 0.09% |
595,500
-5,000
| -0.8% | -$550K |
|
223
NextEra Energy
NEE
$172B
| $63.6M | 0.09% |
724,813
+240,100
| +50% | +$21.7M |
|
224
Axsome Therapeutics
AXSM
$11B
| $63.4M | 0.09% |
259,034
-478,544
| -65% | -$104M |
|
225
NXP Semiconductors
NXPI
$56.3B
| $63.2M | 0.09% |
225,008
+14,500
| +7% | +$4M |
|
Similar funds
Adage Capital Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Adage Capital Partners held 1,130 positions worth $71.3B, up 10% from $64.8B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Adage Capital Partners withdrew a net $2.43B in Q2 2026, closing 128 positions and reducing 392 holdings. Its most notable exit was Centessa Pharmaceuticals, an estimated $355M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Marvell Technology worth $222M.
- Adage Capital Partners's largest Q2 2026 buy was Marvell Technology: 745,800 shares worth $222M.
- Adage Capital Partners added most to Devon Energy in Q2 2026, an estimated $353M increase.
- Adage Capital Partners's biggest Q2 2026 reduction was Revolution Medicines, cutting an estimated $713M.
- Adage Capital Partners fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $355M.
- Adage Capital Partners's ten largest holdings make up 29% of its $71.3B portfolio in Q2 2026.
- Adage Capital Partners opened 174 new positions and closed 128 in Q2 2026.
- Adage Capital Partners's portfolio value rose 10% quarter-over-quarter to $71.3B.
Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.